News coverage about HMS (NASDAQ:HMSY) has been trending somewhat positive recently, according to Accern. The research firm rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. HMS earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news articles about the business services provider an impact score of 45.2938260765801 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the media stories that may have impacted Accern Sentiment’s analysis:
HMS (HMSY) remained flat at $$17.83 on Friday. 369,113 shares of the company traded hands, compared to its average volume of 590,970. HMS has a 1-year low of $11.01 and a 1-year high of $20.90. The company has a market capitalization of $1,500.00, a price-to-earnings ratio of 61.48, a PEG ratio of 2.62 and a beta of 0.88.
HMS (NASDAQ:HMSY) last announced its earnings results on Friday, November 3rd. The business services provider reported $0.19 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.22 by ($0.03). The firm had revenue of $125.70 million for the quarter, compared to the consensus estimate of $147.62 million. HMS had a return on equity of 7.93% and a net margin of 4.94%. HMS’s revenue for the quarter was up 2.3% on a year-over-year basis. During the same quarter last year, the business posted $0.24 EPS. research analysts predict that HMS will post 0.55 earnings per share for the current year.
HMS declared that its Board of Directors has authorized a share buyback program on Friday, November 3rd that permits the company to buyback $50.00 million in outstanding shares. This buyback authorization permits the business services provider to buy shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.
HMSY has been the subject of several recent research reports. BidaskClub raised HMS from a “sell” rating to a “hold” rating in a research report on Wednesday, December 6th. Cantor Fitzgerald reissued a “hold” rating and set a $16.00 price target on shares of HMS in a research report on Sunday, November 19th. Canaccord Genuity reduced their price target on HMS from $22.00 to $17.00 and set a “buy” rating for the company in a research report on Monday, November 6th. Robert W. Baird reaffirmed a “buy” rating and issued a $17.00 price objective on shares of HMS in a research report on Friday, November 10th. Finally, Jefferies Group reaffirmed a “neutral” rating on shares of HMS in a research report on Sunday, November 5th. Six analysts have rated the stock with a hold rating, four have given a buy rating and two have issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $20.39.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/hms-hmsy-earns-media-sentiment-score-of-0-17.html.
HMS Holdings Corp. is a holding company. The Company, through its subsidiaries, operates in the United States healthcare insurance benefit cost containment marketplace. It provides coordination of benefits services to government, and private healthcare payers and sponsors. Its payment integrity services ensure that healthcare claims billed are accurate and appropriate.
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.